1/13
08:00 am
evax
Evaxion expands AI-Immunology™ platform into autoimmune diseases
Low
Report
Evaxion expands AI-Immunology™ platform into autoimmune diseases
1/13
04:05 am
evax
Evaxion A/S (NASDAQ:EVAX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Evaxion A/S (NASDAQ:EVAX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/7
08:00 am
evax
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
Medium
Report
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
12/19
07:49 am
evax
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2 [Yahoo! Finance]
High
Report
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2 [Yahoo! Finance]
12/19
07:00 am
evax
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
High
Report
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
12/6
02:00 pm
evax
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
High
Report
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
11/20
08:00 am
evax
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
Low
Report
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1